Insider Transactions in Q2 2022 at T2 Biosystems, Inc. (TTOO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2022
|
Ninfa Saunders |
BUY
Exercise of conversion of derivative security
|
Direct |
73,224
+36.35%
|
-
|
|
Jun 25
2022
|
John W Cumming |
BUY
Exercise of conversion of derivative security
|
Direct |
81,967
+38.16%
|
-
|
|
Jun 25
2022
|
David B Elsbree |
BUY
Exercise of conversion of derivative security
|
Direct |
73,224
+20.96%
|
-
|
|
Jun 25
2022
|
Seymour Liebman |
BUY
Exercise of conversion of derivative security
|
Direct |
73,224
+23.75%
|
-
|
|
Jun 25
2022
|
Robin Toft |
BUY
Exercise of conversion of derivative security
|
Direct |
73,224
+36.35%
|
-
|
|
Jun 25
2022
|
Thierry Bernard |
BUY
Exercise of conversion of derivative security
|
Direct |
73,224
+36.35%
|
-
|
|
Apr 08
2022
|
Brett A. Giffin Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
10,600
+50.0%
|
$0
$0.49 P/Share
|
|
Apr 08
2022
|
John M Sprague Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+6.16%
|
$0
$0.48 P/Share
|
|
Apr 08
2022
|
Alec Barclay Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
12,951
+6.65%
|
$0
$0.5 P/Share
|
|
Apr 07
2022
|
Michael Terrence Gibbs General Counsel |
BUY
Open market or private purchase
|
Direct |
10,000
+5.66%
|
$0
$0.49 P/Share
|
|
Apr 07
2022
|
John J Sperzel Iii |
BUY
Open market or private purchase
|
Direct |
30,000
+11.92%
|
$0
$0.5 P/Share
|